1. Introduction {#sec1}
===============

Nitroarenes are widespread environmental pollutants found in cigarette smoke, coal fly ash, exhausts from diesel and gasoline engines, and air particulate matter \[[@B1]\]. 3-Nitrobenzanthrone (3NBA, 3-nitro-7H-benz\[de\]anthracen-7-one), a member of this class of compounds, is one of the most potent bacterial mutagens known to date \[[@B2]\] and exhibits strong mutagenic activity in mammalian cells \[[@B3]\]. Human fibroblasts exposed to N-acetoxy-3-aminobenzanthrone, an active metabolite of 3NBA, show predominance of base substitution mutations mainly G → T transversions followed by G → A and A → G substitutions \[[@B4]\]. Transgenic mice treated with 3NBA exhibit increased mutation frequency in liver, colon, bladder, and bone marrow, with G → T transversions dominating this effect \[[@B5], [@B6]\]. Analysis of 3NBA-induced mutations in mouse fibroblasts harboring a functional copy of the human *p53* gene also reveals a preponderance of G → T transversions, followed by adenine base substitutions \[[@B7]\]. In addition to mutations, 3NBA causes DNA double-strand breaks and induces the formation of micronuclei in human cell lines \[[@B8], [@B9]\]. Female F344 rats treated with 3NBA by intratracheal instillation show acute and subacute changes in their lungs just few weeks after treatment and develop squamous cell lung tumors within 9 to 12 months, depending on the amount of 3NBA administered \[[@B10]\]. Some epidemiological evidence links environmental 3NBA exposure to lung cancer in humans \[[@B11], [@B12]\].

Like other environmental nitroarenes, 3NBA undergoes metabolic transformation to reactive electrophilic intermediates before binding to DNA and exerting its genotoxic effects. In rats, mice and humans, cytosolic NAD(P)H:quinone oxidoreductase (NQO1) is the main enzyme that reduces 3NBA to *N*-hydroxy-3-aminobenzanthrone (*N*-OH-3-ABA), which after further activation by phase II enzymes (*N-,O-*acetyl transferases, sulfotransferases) can react with DNA forming purine adducts ([Figure 1](#fig1){ref-type="fig"}) \[[@B13], [@B14]\]. NADPH:cytochrome P450 reductase can also activate 3NBA to reactive species in human cells \[[@B15]\], but its involvement seems to occur to a minor extent than that of NQO1. A fully reduced 3NBA metabolite, namely, 3-aminobenzanthrone (3ABA), has been recovered from urine of humans occupationally exposed to diesel exhaust \[[@B16]\]. 3ABA can undergo CYP1A1-mediated (or CYP1A2-) oxidation to the same *N*-hydroxyl intermediate generated by the reductive metabolism, indicating a further mechanism for the activation and the genotoxicity of 3NBA \[[@B17], [@B18]\]. In addition, because 3NBA induces increased levels of NQO1 and CYP1A1 proteins in rat lung and kidney tissues, its genotoxicity may be enhanced by autoinduction of its metabolic pathway \[[@B14]\].

The reactive metabolite of 3NBA, *N*-OH-3-ABA, can react with DNA *in vitro*and*in vivo*forming purine adducts. Up to five adducts are detected in rodent samples utilizing the TLC-^32^P-postlabeling techniques with enrichment by butanol extraction \[[@B5], [@B19]--[@B21]\]. HPLC comparison of these spots with synthetically prepared adduct standards \[[@B22]\] showed that 2-(2′-deoxyguanosin-*N*^2^-yl)-3-aminobenzanthrone (dG(*N*^2^)-3ABA), *N*-(2′-deoxyguanosin-8-yl)-3-aminobenzanthrone (dG(C8)-ABA), and 2-(2′-deoxyadenosin-*N*^6^-yl)-3-aminobenzanthrone (dA(*N*^6^)-3ABA) are the mayor adducts formed in rats organs after 3NBA administration \[[@B21]\]. Although the synthesis of the above-mentioned 3ABA adducts and their corresponding N-acetyl forms has been reported \[[@B23]\], their incorporation in oligodeoxyribonucleotides has not been reportted. To understand the molecular mechanisms of 3NBA mutagenesis as well as the repair of 3NBA-damaged DNA, a procedure for the site-specific incorporation 3ABA lesions in oligomeric 2′-deoxyribonucleotides is essential. In the present article, we present a synthetic scheme that allows the preparation of oligomeric DNA containing the dG(*N*^2^)-3ABA adduct ([Figure 1](#fig1){ref-type="fig"}), one of the major DNA lesions generated by NBA *in vivo* \[[@B21]\]. The synthetic approach is robust permitting the incorporation of the adduct in any sequence context. We also present results showing that the presence of dG(*N*^2^)-3ABA increases the stability of the damaged duplex, a finding previously observed with other dG(*N*^2^) lesions, including the *N*^2^-deoxyguanosine derivative of AAF, 2-(2′-deoxyguanosin-*N*^2^-yl)-2-acetylaminofluorene \[[@B24]\]. Interestingly, both of these kinds of damage are characterized by an unusually long persistence in rat tissues \[[@B21], [@B25]\], suggesting that lack of thermodynamic destabilization by bulky lesions is a factor that hinders the recognition of the lesions by the nucleotide excision repair (NER) pathway.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals {#sec2.1}
--------------

All general chemicals were purchased from Sigma-Aldrich (St. Louis, Mo), and solid-phase DNA synthesis reagents from Glen Research Co. (Sterling, Va). *S*-benzyl thiotetrazole was crystallized from toluene and dried *in vacuo* over P~2~O~5~ before use.

2.2. Mass Spectrometry (MS) {#sec2.2}
---------------------------

Electrospray ionization-mass spectrometry (ESI-MS) and tandem MS (MS/MS) experiments were carried out on TSQ Quantum Access (Thermo Scientific) and LTQ Orbitrap XL (Thermo-Fisher Scientific) spectrometers. A 50 : 50 : 1 v/v mixture of acetonitrile : water : triethylamine was used as the solvent for electrospray MS determinations. High-resolution mass spectra (HRMS) were acquired on the LTQ Orbitrap XL (Thermo-Fisher Scientific) equipped with an electrospray ionization (ESI) source. The spray voltage was set to 3.0 kV and the temperature of the heated capillary was maintained at 300°C. Measurements were done in a positive ion mode with an injection time of 200 ms and an infusion rate of 3 uL/min in 90% acetonitrile/water.

2.3. Stability Studies {#sec2.3}
----------------------

Duplex denaturation profiles were recorded on a Cary 100 Bio UV-VIS spectrophotometer (Varian, Inc., Palo Alto, Calif). DNA duplexes were dissolved in 25 mM sodium phosphate buffer, pH 6.8, containing 150 mM NaCl and 500 *μ*M EDTA. Sample absorbance was recorded every 20 s within the 10--80°C range. Determinations proceeded while heating and cooling the sample, using a temperature change rate of 0.2°C/min. Duplex melting temperature (*T*~*m*~) was obtained by the first derivative method. Thermodynamic parameters were obtained from the analysis of 1/*T*~*m*~ versus ln(*C*~*t*~) plots (van\'t Hoff plots), whose slope and intercept yield ΔH and ΔS, respectively \[[@B26]\].

2-(3′,5′-Bis-O-Tert-Butyldimethylsilyl-O^6^-2-(4-Nitrophenylethyl)-2′-Deoxyguanosin-*N*^2^-yl)-3-Nitrobenzanthrone **(1)**It was synthesized according to a previously published procedure \[[@B23]\]. The final material was purified by crystallization from methanol, instead of the reported column chromatography method. The ^1^H-NMR spectrum of **1**was essentially identical to that previously published \[[@B23]\].

2-(O^6^-2-(4-Nitrophenylethyl)-2′-Deoxyguanosin-*N*^2^-yl)-3-Nitrobenzanthrone **(3)**Silylated nucleoside **1** (255 mg, 0.25 mmol) was dissolved in 3 mL of a dimethylformamide : triethylamine trihydrofluoride : triethylamine mixture (6 : 4 : 3) and heated at 50°C for 1 hour. The mixture was poured into 50 mL of ethyl acetate, centrifuged, the residue rinsed with ethyl acetate, and dried *in vacuo* over P~2~O~5~, yielding 131 mg (0.19 mmol, 78%) of **3** as a fine red powder. For NMR spectroscopy, the sample was resuspended in ethyl acetate, centrifuged, and dried. ^1^H-NMR (DMSO-*d~6~*, TMS, *δ* (p.p.m.)): 9.87 (br. s., 1H), 9.20 (s. 1H), 8.55 (d, 1H), 8.49 (d, 1H), 8.32 (s, 1H), 8.28 (m, 2 H), 7.99 (t, 1H), 7.92 (d, 2 H, *J* = 8.0 Hz), 7.83 (t, 1H), 7.66 (t, 1H), 7.37 (d, 2 H, *J* = 8.0 Hz), 6.29 (t, 1H, *J* = 6.0 Hz), 5.21 (br s, 1H), 4.83 (br s, 1H), 4.66 (br s, 2 H), 4.31 (br s, 1H), 3.81 (br s, 1H)3.50-3.46 (m, 3 H), 2.63--2.52 (m, 2 H) (Supplementary Material available at doi: 10.4061/2011/521035). ^13^C-NMR (DMSO-*d~6~*, TMS, *δ* (p.p.m.)): 128.23, 159.00, 154.67, 153.08, 146.17, 146.08, 139.78, 137.86, 134.34, 133.98, 132.60, 130.27, 129.97, 129.56, 128.20, 127.58, 127.32, 124.99, 124.55, 123.82, 123.17, 123.05, 116.37, 87.84, 83.10, 70.66, 66.07, 61.56, 45.60, 34.13 (Supplementary Material). HRMS: observed \[M + H\]^+^ 690.1923; calculated 690.1943.

2-(5′-O-Dimethoxytriphenylmethyl-O^6^-2-(4-Nitrophenylethyl)-2′-Deoxyguanosin-*N*^2^-yl)-3-Nitrobenzanthrone **(4)**Nucleoside **3** (120 mg, 0.17 mmol) was coevaporated with pyridine, redissolved in 2 mL of dry pyridine, mixed with 120 mg of dimethoxytrityl chloride (0.35 mmol), and left for 12 hour at room temperature. After disappearance of the starting material (estimated by TLC analysis), the reaction mixture was diluted with 20 mL of ethyl acetate, extracted with 10% sodium citrate (3 × 100 mL), dried with sodium sulfate, and evaporated *in vacuo.*Flash chromatographic purification of the residue (5% triethylamine in methylene chloride) yielded 123 mg (0.125 mmol, 73%) of **4**as a deep red transparent glassy solid. ^1^H-NMR (CDCl~3~, TMS, *δ* (p.p.m.)): 9.93 (s, 1H), 9.21 (s, 1H), 8.68 (d, 1H, *J* = 6.5 Hz), 8.50 (d, 1H, *J* = 6.9 Hz), 8.49 (d, 1H, *J* = 8.7 Hz), 8.39 (d, 1H, *J* = 8.7 Hz), 8.12 (d, 2 H, *J* = 8.3 Hz), 7.98 (s, 1H), 7.90 (t, 1H, *J* = 7.8 Hz), 7.8 (t, 1H, *J* = 7.5 Hz), 7.63 (t, 1H, *J* = 7.0 Hz), 7.47 (d, 2 H, *J* = 8.0 Hz), 7.38 (d, 2 H, *J* = 7.2 Hz), 7.28--7.26 (m), 6.78 (d, 4 H, *J* = 8.2 Hz), 6.58 (t, 1H, *J* = 6.1*H*z), 4.83 (t, 2 H, *J* = 7.2 Hz), 4.67 (m, 1H), 4.21 (m, 1H), 3.76 (s, 6 H), 3.44 (m, 1H), 3.35--3.30 (m, 3 H), 2.85 (br s, 1H), 2.81--2.79 (m, 1H), 2.65--2.64 (m, 1H) (Supplementary Material). ^13^C-NMR (CDCl~3~, TMS, *δ* (p.p.m.)): 183.2, 160.8, 158.8, 154.0, 153.5, 152.6, 150.4, 147.0, 145.8, 144.6, 139.0, 135.8, 135.7, 134.3, 134.2, 133.2, 131.2, 130.7, 130.3, 130.2, 130.1, 129.3, 129.1, 128.3, 128.2, 128.0, 127.9, 127.6, 127.2, 125.9, 123.9, 123.2, 117.6, 116.2, 115.0, 114.5, 113.5, 113.4, 87.0, 86.9, 83.9, 72.9, 68.1, 67.2, 56.1, 56.0, 55.4, 52.9, 46.0, 32.2, 25.7 (Supplementary Material). HRMS: observed \[M + H\]^+^ 992.3227, calculated 992.3250.

2-(3′-O-(Cyanoethoxydiisopropylaminophosphino)-5′-O-Dimethoxytriphenylmethyl-O^6^-2-(4-Nitrophenylethyl)-2′-Deoxyguanosin-*N*^2^-yl)-3-Nitrobenzanthrone **(5)**Nucleoside **4** (112 mg, 0.11 mmol) was coevaporated with toluene, dissolved in 2 mL of dry THF under argon, mixed with 200 *μ*L of diisopropyl ethylamine, followed by the addition of 104 *μ*L (0.37 mmol) of 2-cyanoethoxy diisopropyl chlorophosphoramidite. The mixture remained at room temperature for 6 hours. After disappearance of the starting material (assayed by TLC analysis), the mixture was dissolved in 30 mL of ethyl acetate and washed with 10% potassium carbonate (2 × 50 mL). The organic layer was dried with sodium sulfate and evaporated *in vacuo.* The resulting viscous oil was purified by reverse-phase chromatography using an acetonitrile-water gradient (60--100%, over 15 min) as the mobile phase, yielding **5**(98 mg, 0.082 mmol, 74%) as a deep-red colored transparent glassy solid. The ^1^H-NMR spectrum had a double set of signals, of 55--45 intensity ratio, which corresponded to the diastereomers related to the phosphorus atom. ^1^H-NMR (CDCl~3~, TMS, *δ* (p.p.m.), chemical shifts for the major component are (given when possibe) 9.79 (s, 1H), 9.82 (s, 1H), 8.71 (d, 1H), 8.52 (d, 1H), 8.50 (d, 1H), 8.37 (t, 1H), 8.10 (t, 1H), 8.00 (s, 1H), 7.92 (t, 1H), 7.73 (t, 1H), 7.63 (t, 1H), 7.43--7.39 (m, 4 H), 7.29--7.17 (m), 7.19 (t, 1H), 7.90 (d, 2 H), 7.60 (d, 2 H), 6,50 (m, 1H), 4.82 (br t, 2 H), 4.72 (m, 1H), 4.28 (m, 1H), 3.76 (s, 3 H), 3.75 (t, 3 H), 3.66--3.43 (m, 4 H), 3.44--3.35 (m, 2 H), 3.30 (br t, 2 H), 2.86 (sept, 1H), 2.71 (m, 1H), 2.45 (m, 1H), 1.53 (m, 12 H) (Supplementary Material). HRMS: observed \[M + H\]^+^ 1192.4365, calculated 1192.4328.

2.4. Oligodeoxyribonucleotide Synthesis {#sec2.4}
---------------------------------------

It was performed on an ABI DNA synthesizer using UltraMild CE phosphoramidites and *S*-benzylthio-tetrazole as the activator reagent. Standard procedures were used for the preparation of unmodified oligodeoxyribonucleotides. A four-fold molar excess of amidite was used and the coupling time was increased to 5 minutes for introduction of the xenonucleotide moiety. Oligodeoxyribonucleotide cleavage from the solid support and subsequent deprotection was accomplished by overnight incubation with concentrated aqueous ammonia at room temperature. After evaporation *in vacuo*, the synthetic products were purified by reverse-phase chromatography. Purification was performed on a Gilson HPLC system with UV monitoring at 260 and 290 nm, a 7.5 × 250 mm Zorbax ODS column (5 *μ*M particle size, 300 Å pore size), using a linear acetonitrile gradient (5 to 50%, 30 min) in 50 mM triethylammonium acetate, pH 6.5, at flow rate of 5 mL/min. Purified oligodeoxyribonucleotides were lyophilized and the 5′-DMT group was removed by co-evaporation with an 80% acetic acid solution. The residue was dissolved in 2 mL 1 M tetrabutylammonium chloride, purified by HPLC using the protocol described above, and lyophilized to dryness. The resulting product was dissolved in water (1 mL) and 100 *μ*L 1 M sodium sulfide was added. The immediate color transition from an orange-red to a deep purple attested that the reduction of nitro group had taken place. After standing for 1 hr at room temperature, the reaction mixture was purified by HPLC yielding the desired oligodeoxyribonucleotide product, which was lyophilized, precipitated from ethanol in sodium form and subsequently desalted using a Sephadex G-10 column.

2.5. NMR Spectra {#sec2.5}
----------------

One- and two-dimensional ^1^H NMR spectra were recorded using Varian (Inova) or Bruker (Avance) spectrometers operating at 9.4, 11.75, or 14.1 T field strengths. Proton chemical shifts were referenced relative to tetramethyl silane (for organic solvents) or sodium 3-(trimethylsilyl) propionate-2,2,3,3-*d*~4~ (for water solutions) at 0 ppm. Phase-sensitive NOESY (300 ms mixing times) and DQF-COSY spectra of the damaged duplex were collected at 25°C with the sample dissolved in 50 mM phosphate buffer solution (pH 6.9) in 100% D~2~O. The residual water signal was suppressed by presaturation during the repetition delay of 1.5 s. NMR data were processed and analyzed using NMRPipe \[[@B27]\] and Sparky \[[@B28]\], running in Linux workstations. Datasets consisted of 4096 and 256 complex data points in the *t*~2~ and *t*~1~ dimensions, respectively. Time domain data were multiplied by a shifted sine-bell window function and zero filled to 4096 points. Polynomial baseline correction was applied to the frequency domain data.

3. Results and Discussion {#sec3}
=========================

3.1. Preparation of the dG(*N*^2^)-3ABA Containing Oligodeoxyribonucleotide {#sec3.1}
---------------------------------------------------------------------------

A general synthetic method for the introduction of modified dG moieties having aminoaryl or N-acetylaminoaryl substitutions (xenonucleotides) is the use of the 2-(N-trifluoroacetylaminoaryl)-deoxyguanosine phosphoramidite during conventional phosphoramidite solid phase synthesis \[[@B29]\]. In this approach, the key nitroarene precursor is obtained via a palladium-mediated condensation of protected 2′-deoxyguanosine with the corresponding bromo nitroarene \[[@B30]\], followed by deprotection, nitro-reduction and trifluoroacetylation. Despite its simplicity and versatility, this method showed some drawbacks in the dG(*N*^2^)-3ABA case. First, the direct reduction of the nitro group and ensuing trifluoroacetylation lead to a complex mixture of products, a complication that, in principle, can be prevented by using additional deprotection and protection steps. Second, the use of trifluoroacetyl protection imposes some restrictions on the conditions of solid phase synthesis and oligodeoxyribonucleotide deprotection that reduced final yields. To overcome these problems, we decided to introduce dG(*N*^2^)-3NBA directly during oligodeoxyribonucleotide synthesis and generate the amino group of the adduct by a postsynthesis treatment. Using standard procedures \[[@B23], [@B30]\], we readily prepare the protected dG(*N*^2^)-3NBA nucleoside (**1**). Treatment of **1**with TBAF removes the oxygen protecting groups (TBDMS and p-NO~2~-phenetyl (NPE)), yielding the fully deprotected adduct (**2**) ([Scheme 1](#sch1){ref-type="fig"}). This compound, however, produces a complex mixture of products during the subsequent synthesis steps (data not shown), making it an unsuitable intermediate. A possible explanation is that the unprotected dG(*N*^2^)-3NBA (**2**) has poor solubility in both water and organic solvents, impeding its purification by standard treatments including liquid-liquid extraction and column chromatography. In addition, this compound seems to exist in several protonation states, a fact easily seen by sharp color changes, from violet-purple to deep blue to deep green, upon transition to higher pH. Therefore, we decided to keep the guanine-O^6^ protecting group on during the phosphoramidite preparation and solid phase synthesis. Treatment of (**1**) with a TEA·3HF : TEA : DMF mixture removes the TBDMS protection leaving the NPE group intact. Nucleoside (**3**) is then 5′-dimethoxytritylated to give **4** which, in turn, is converted to the corresponding phosphoramidite (**5**) using the standard protocol ([Scheme 1](#sch1){ref-type="fig"}). Coupling of the xenonucleotide phosphoramidite shows 90--95% efficiency during solid phase oligonucleotide synthesis.

We tested two possible approaches for the postsynthetic deprotection of the oligodeoxyribonucleotide and reduction of the nitro group. The first one was the removal of the guanine-O^6^ protecting group by treatment of the synthesis product, still attached to the solid support, with 1 M DBU/DMF, followed by reduction of the nitro group with 1 M sodium dithionite/sodium citrate at pH 7.0. Subsequent treatment with concentrated ammonia should remove the other protecting groups and cleave the oligodeoxyribonucleotide from the solid support. However, during the ammonia treatment we observed considerable color changes, suggesting a partial degradation of the dG(*N*^2^)-3ABA moiety and the final yield was unacceptably low for large-scale synthesis. Utilization of mild deprotection phosphoramidites diminished the problem but did not eliminate it. Therefore, we used an alternative strategy that proved to be successful. After solid phase synthesis, treatment with concentrated ammonia at room temperature cleaved the tritylated oligodeoxyribonucleotide from the solid support and removed the acyl and cyanoethyl protecting groups. After solvent evaporation and purification by reverse phase HPLC, ESI-MS confirmed that the major product was the NPE-protected dG(*N*^2^)-3NBA containing oligomer (**6**). Subsequent treatment with TBAF removed the NPE protecting group and addition of 1 M Na~2~S reduced the nitro group of dG(*N*^2^)-3NBA to the corresponding amino of dG(*N*^2^)-3ABA (**7**) with excellent yields ([Scheme 2](#sch2){ref-type="fig"}). After purification of the reaction products by an additional HPLC run, ESI-MS analysis showed that the main product was the desired dG(*N*^2^)-3ABA containing oligodeoxyribonucleotide (Supplementary Material).

3.2. NMR Spectra of the dG(*N*^2^)-3ABA Duplex {#sec3.2}
----------------------------------------------

Two-dimensional NMR spectroscopy confirmed the presence of 3ABA in the purified sample and allowed the assignment of its aromatic protons ([Figure 2](#fig2){ref-type="fig"}). The aromatic region of an NOESY (300 ms mixing time) spectrum in 100% D~2~O phosphate buffer, pH 6.9, revealed a single set of reasonably sharp proton signals, indicating that the damaged duplex assumes a major stable conformation at room temperature ([Figure 2(a)](#fig2){ref-type="fig"}). NOE interactions were particularly strong among 3ABA protons, readily differentiating them from cross-peaks originated from the aromatic nucleotide protons of the duplex ([Figure 2(b)](#fig2){ref-type="fig"}). The identical region of a DQF-COSY spectrum was very simple since its diagonal only shows signals for protons that have scalar coupling, specifically cytosine-H6 and 3ABA protons. Thus, the 3ABA(H1) proton was absent on the DQF-COSY spectrum (denoted by an arrow) but exhibited a strong NOE interaction with 3ABA(H11), which is very close in space across the bay region of 3ABA ([Figure 2](#fig2){ref-type="fig"}). From here, identification of the remaining 3ABA protons was straightforward, with the exceptions of H4 and H6 whose specific assignments remained ambiguous. Labels in [Figure 2](#fig2){ref-type="fig"} list the assignment of 3ABA protons.

[Figure 3](#fig3){ref-type="fig"} displays the expanded base-H1′ sugar proton region of the same 300 ms mixing time NOESY spectrum. Each base proton (purine(H8) or pyrimidine(H6)) of the duplex exhibited NOE interactions to its own and the 5′-flanking H1′ sugar protons, indicating that the 3ABA-damaged duplex adopts a right-handed helical conformation in solution. The bulky aromatic moiety, however, did induce some perturbations of the ideal B-form conformation, as evidenced by the absence of the A11(H8)-A11(H1′) intraresidue interaction ([Figure 3](#fig3){ref-type="fig"}, empty box) and the weak intensity detected for the A11(H8)-C10(H1′) and A13(H8)-T12(H1′) cross-peaks. In addition, several proton signals exhibited unusual chemical shift values, including C6(H1′) and A11(H1′), that resonate at 4.43 and 5.34 ppm, respectively, suggesting that the 3ABA moiety resides in the duplex minor groove pointing towards the 5′-end of the modified strand. These chemical shift values are reminiscent of those observed on duplexes containing other bulky adducts positioned in minor groove, such as dG(*N*^2^)-AAF, a minor acetylaminofluorene lesion previously characterized by our laboratory \[[@B24]\], or the extensively studied *trans* dG(*N*^2^)-B\[a\]P adducts \[[@B31], [@B32]\].

3.3. Stability of the dG(*N*^2^)-3ABA Duplex {#sec3.3}
--------------------------------------------

Analysis of UV melting curves shows that the melting temperature of the self-complementary dG(*N*^2^)-3ABA duplex is about 7.5°C higher than that of the unmodified control sample ([Figure 4](#fig4){ref-type="fig"}). Van\'t Hoff thermodynamic parameters for the damaged duplex indicate a large entropy increase that overcompensates for the 2.6 kcal/mol enthalpy increase, resulting in 3.0 kcal/mol reduction of Gibbs\'s free energy at 30°C ([Table 1](#tab1){ref-type="table"}). Due to duplex symmetry, there are two dG(*N*^2^)-3ABA adducts per duplex molecule, which in principle, can contribute independently to Gibbs\'s free energy reduction or display additional interactions between themselves. Since the 3ABA duplex has four undamaged G·C base pairs (that showed regular NOE interactions) separating the damaged nucleotides, the ABA moieties are too far apart (17 Å in B-form DNA) to expect any direct interaction between them. Therefore, the duplex stabilizing effect of a single dG(*N*^2^)-3ABA lesion in the 5′-TXC sequence context is 1.5 kcal/mol at 30°C.

Notwithstanding the absence of a refined three-dimensional model of the dG(*N*^2^)-3ABA duplex, it is interesting to compare the stability impact of the different dG(*N*^2^) minor groove lesions. Our previous study of the dG(*N*^2^)-AAF-containing duplex revealed a considerable stabilization on the double helix by the acetylaminofluorene moiety. The hydrophobic fluorene moiety resides deep in the minor groove of the duplex, displacing water molecules and exposing only 10% of its surface to solvent. As a result, a significant entropy increase more than compensates for the moderate enthalpy destabilization of the duplex, causing a 1.8 kcal/mol reduction of Gibb\'s free energy per lesion \[[@B24]\], somewhat larger that the effect observed here for the dG(*N*^2^)-3ABA adduct. Similar to the AAF case, the dG(*N*^2^)-3ABA lesion resides in the duplex minor groove and exhibits an almost identical topology along the bay region edge of the adduct ([Figure 5](#fig5){ref-type="fig"}). It is natural to expect, however, that the 3ABA moiety, being bulkier than the AAF residue, would extend beyond the boundaries of the minor groove, exposing a greater fraction of its hydrophobic ring system to water, thus diminishing the overall stabilizing effect relative to the former. In addition, the 5′ lesion-flanking base pair differs on the dG(*N*^2^)-AAF and dG(*N*^2^)-3ABA duplexes and its contribution to the stability increase can be slightly different. In contrast to the case of the AAF and 3ABA lesions, the presence of dG(*N*^2^)-(*trans*)B\[a\]P reduces the thermodynamic stability of the damaged duplex \[[@B33]\]. A main structural difference in the latter case is the topology of the lesion ([Figure 5](#fig5){ref-type="fig"}), most importantly the sp^3^ hybridization of the linkage carbon that results in the exposure of one face of the B\[a\]P moiety to solvent \[[@B31], [@B32]\]. In addition, differences on sequence context between the dG(*N*^2^)-3ABA and dG(*N*^2^)-(*trans*)B\[a\]P lesion may also play a role in explaining the stability effects of these adducts.

The DNA stabilizing effect of dG(*N*^2^)-3ABA is shared by only few bulky lesions, specifically the dG(*N*^2^)-AAF adduct \[[@B24]\], the dG(*N7*) and fapy-dG adducts of aflatoxin B~1~ \[[@B34], [@B35]\]. In contrast to AAF and aflatoxin B~1~, 3-nitrobenzanthrone is an abundant environmental pollutant in developed countries and the properties of 3-NBA generated lesions may help explain the incidence of random mutations and sporadic cancers. The current models of the nucleotide excision repair (NER) pathway postulates that the recognition of bulky lesions is mediated by sensing the local instability \[[@B36]--[@B38]\] or alteration of conformational mobility \[[@B39]\] induced by the adducts. In excellent agreement with these concepts, the increased thermodynamic stability of duplex DNA containing dG(*N*^2^)-AAF adducts correlates well with the unusually long lifetime of this lesion in rat genomic DNA \[[@B25]\]. Recent studies have found that dG(*N*^2^)-3ABA persists in rat DNA for a long period of time after a single instillation of 3NBA \[[@B21]\]. Our observations that dG(*N*^2^)-3ABA increases duplex stability and adopts a single conformation in solution point to a mechanistic explanation for its persistence in cellular DNA. However, a careful examination of the recognition of the dG(*N*^2^)-3ABA damage by the NER system is needed before these ideas can be confirmed. Such investigations and the NMR structure determination of dG(*N*^2^)-3ABA-containing DNA are currently in progress.

4. Conclusions {#sec4}
==============

The environmental pollutant 3-nitrobenzanthrone is one of the most potent bacterial mutagens and has strong mutagenic activity in mammalian cells. After cellular activation to electrophilic intermediates, it reacts with DNA forming purine adducts including the prevalent dG(*N*^2^)-3ABA lesion. We reported here an efficient synthetic method for incorporation of this lesion in oligomeric DNA in any sequence context, opening the door to future site-specific mutagenesis and DNA repair studies. We also presented evidence showing that dG(*N*^2^)-3ABA increases the stability of the damaged duplex, a finding previously observed with other dG(*N*^2^) lesions and that is associated with the long persistence of the adducts in rat tissues. Our results suggest that the lack of thermodynamic destabilization of DNA is a key factor during the recognition of bulky the lesions by the NER pathway.

Supplementary Material {#supplementary-material-sec}
======================
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^1^H, ^13^C and high-resolution mass spectra of nucleoside derivatives 3, 4 and 5; a summary table of the high-resolution mass spectra of the same compounds and the ESI mass spectra of the dG(*N*^2^)-3NBA and dG(*N*^2^)-3ABA 14-mer duplexes is available.
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![Metabolic activation of 3-nitrobenzanthrone and DNA adduct formation. NQO1, NAD(P)H:quinone oxidoreductase; CYPOR, NADPH:cytochrome P450 (P450) reductase; CYP1A1/2, cytochrome P450 1A1/2; NAT1A1/2, *N,O* acetyltranferases; SULT1A1/2, sulfotransferase 1A1/2; dG(C8)-ABA, *N*-(2′-deoxyguanosin-8-yl)-3-aminobenzanthrone; dG(*N*^2^)-3ABA, 2-(2′-deoxyguanosin-*N*^2^-yl)-3-aminobenzanthrone; dA(*N*^6^)-3ABA, 2-(2′-deoxyadenosin-*N*^6^-yl)-3-aminobenzanthrone. Numbering of the benzanthrone moiety is shown in the dG(*N*^2^)-3ABA adduct.](JNA2011-521035.001){#fig1}

![Expanded contour plot of a 300 ms mixing time NOESY spectrum (600 MHz) of the 14-mer dG(*N*^2^)-3ABA duplex dissolved in 100% D~2~O phosphate buffer, pH 6.9 (left), depicting NOE interactions among the aromatic protons of the duplex. NOE peaks are particularly strong among the aromatic 3ABA protons facilitating their assignment. Especially relevant is the 3ABA(H1-H11) cross-peak which allows identification of the different aromatic rings. Identical region of a DQF-COSY spectrum recorded under the same conditions (right) showing J-coupling interactions that confirms the NOE-based assignments. The arrow points to the position of the H1 diagonal peak, which is missing on the DQF-COSY spectrum due to the absence of coupling interactions. Labels show the specific assignments of the aromatic protons of 3ABA, with the exception of H4 and H6 where it was not possible. The numbering scheme is shown in [Figure 1](#fig1){ref-type="fig"}.](JNA2011-521035.002){#fig2}

![Expanded contour plot showing the finger print region of a 300 ms mixing time NOESY spectrum (600 MHz) of the 14-mer dG(*N*^2^)-3ABA duplex dissolved in 100% D~2~O phosphate buffer, pH 6.9. The labels identify cross-peaks between the purine(H8), or pyrimidine(H6), and the H1′ sugar proton of the same residue. Asterisks indicate cytosine(H5-H6) interactions. Other labels are assigned as follows: A, 3ABA(H2)-G5(H1′); B, 3ABA(H3)-G5(H1′); C, 3ABA(H3)-T12(H1′). The arrow points to the position of C6(H1′) that resonates outside of the plotted region, at 4.43 ppm.](JNA2011-521035.003){#fig3}

![Typical melting curves of the dG(*N*^2^)-3ABA-containing (circles) and unmodified (triangles) 14-mer duplexes, with open symbols showing their first derivative curves (a). (1/*T*~*m*~) versus ln\[*C*\] plots for the same oligonucleotides (b).](JNA2011-521035.004){#fig4}

![Bay regions (in bold) of dG-*N*^2^ adducts formed by 3-nitrobenzanthrone (a), acetylaminofluorene (b), and B\[a\]P (c).](JNA2011-521035.005){#fig5}

![Synthesis of protected dG(*N*^2^)-3ABA phosphoramidite. (a) 1 M tetrabutylammonium fluoride, THF; (b) triethylamine trihydrofluoride : triethylamine : DMF (4 : 3 : 6); (c) dimethoxytrityl chloride, pyridine; (d) cyanoethoxy diisopropylamino chlorophosphine.](JNA2011-521035.sch.001){#sch1}

![Deprotection and nitro reduction of dG(*N*^2^)-NBA in oligonucleotides. (a) 1 M tetrabutylammonium fluoride, THF; (b) 1 M Na~2~S.](JNA2011-521035.sch.002){#sch2}

###### 

Thermodynamic parameters of ABA-modified and unmodified tetradecamer duplexes.

                            Δ*H*~25~°, kcal/mol   Δ*S*~25~°, cal/mol·K   Δ*G*~25~°, kcal/mol   Δ*G*~37~°, kcal/mol   ΔΔG~37/lesion~°, kcal/mol
  ------------------------- --------------------- ---------------------- --------------------- --------------------- ---------------------------
  dG(*N*^2^)-3 ABA duplex   −95 ± 8               −252 ± 24              −21 ± 1.1             −17.9 ± 0.8           −1.5
  Control duplex            −98 ± 4               −267 ± 11              −18.2 ± 0.5           −14.9 ± 0.3           
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